Non-preventable cases of breast, prostate, lung, and colorectal cancer in 2050 in an elimination scenario of modifiable risk factors

Author:

Palshof Frederik Knude,Mørch Lina Steinrud,Køster Brian,Engholm Gerda,Storm Hans Henrik,Andersson Therese M.-L.,Kroman Niels

Abstract

AbstractMost Western countries have increasing number of new cancer cases per year. Cancer incidence is primarily influenced by basically avoidable risk factors and an aging population. Through hypothetical elimination scenarios of multiple major risk factors for cancer, we estimated the number of new cancer cases that are non-preventable in 2050. We compare numbers of new postmenopausal breast, prostate, lung, and colorectal cancer cases in 2021 to projected numbers of new cases in 2050 under prevention scenarios regarding smoking, overweight and obesity, and alcohol consumption: no intervention, 50%, and 100% instant reduction. Cancer incidence data were derived from NORDCAN, and risk factor prevalence data from the Danish National Health Survey. Cancer projections were calculated with the Prevent program. Hypothetical 100% instant elimination of major risk factors for cancer in Denmark in 2022 will result in unchanged numbers of new breast and colorectal cancers in 2050. The number of new prostate cancers will increase by 25% compared to 2021. Unchanged risk factor levels will result in noticeable increase in cancer burden. Increase in life expectancy and age will entail an increase in cancer incidence, despite maximum effect of preventive actions in the population. Our results are important when planning future health care.

Funder

Kræftens Bekæmpelse

Johannes Clemmesens Forskningsfond

Publisher

Springer Science and Business Media LLC

Reference55 articles.

1. © International Agency for Research on Cancer. Age-standardized rate (World) per 100 000, incidence, males and females. Cancer Over Time (2024).

2. Larønningen S et al. NORDCAN. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 9.3 (02.10.2023). Association of the Nordic Cancer Registries. Cancer Registry of Norway. https://nordcan.iarc.fr/en/about#bloc3 (2023).

3. Larønningen, S. et al. Nordcan.R: A new tool for federated analysis and quality assurance of cancer registry data open access edited by. Front. Oncol 13, 1098342 (2023).

4. NORDCAN IARC. NORDCAN Predicted Absolute Numbers of Colorectal, Lung, Breast, and Prostate cancer in Denmark. https://nordcan.iarc.fr/en/dataviz/predictions_trends?populations=208&scale=linear&smoothing=0&num_path=2&types=0&years_available=1943_2020&mode=cancer&multiple_populations=0&multiple_cancers=1&cancers=180_240_160_520&key=total&sexes=1_2&age_end=17&group_cancers=0&pred_method=nordpred&pred_nb_period=&pred_recent= (2022).

5. Engholm, G. et al. NORDCAN—A Nordic tool for cancer information, planning, quality control and research. Acta Oncol. (Madr.) 49, 725–736 (2010).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3